ORASURE TECHNOLOGIES INC Logo

ORASURE TECHNOLOGIES INC

Develops non-invasive diagnostic products and sample collection tools.

OSUR | US

Overview

Corporate Details

ISIN(s):
US68554V1089
LEI:
Country:
United States of America
Address:
220 E FIRST ST, 18015 BETHLEHEM

Description

OraSure Technologies, Inc. develops, manufactures, and distributes diagnostic products and sample collection tools. The company specializes in non-invasive technologies, particularly oral fluid-based solutions, to decentralize diagnostics and improve healthcare access. Its portfolio includes point-of-care and over-the-counter rapid tests for infectious diseases such as HIV and COVID-19. A notable achievement is the development of the first over-the-counter at-home HIV test. Through its subsidiaries, OraSure also provides sample management solutions for the collection of biological samples used in genomic, metabolomic, and microbiome research, serving healthcare providers, researchers, and consumers.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-12-19 17:08
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
English ZIP 6.8 KB
2025-12-17 17:09
DEFA14A
English ZIP 79.4 KB
2025-12-17 09:06 English ZIP 358.0 KB
2025-12-04 19:45 English ZIP 7.1 KB
2025-12-02 22:17
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
English ZIP 6.8 KB
2025-12-02 22:16
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
English ZIP 8.8 KB
2025-12-02 22:16
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
English ZIP 6.7 KB
2025-12-01 13:37
8-K
English ZIP 55.1 KB
2025-11-17 22:06 English ZIP 12.3 KB
2025-11-05 23:23
10-Q
English ZIP 1.2 MB
2025-11-05 22:50
8-K
English ZIP 2.2 MB
2025-10-28 21:29
8-K
English ZIP 56.8 KB
2025-10-09 19:48 English ZIP 9.5 KB
2025-09-26 22:26
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
English ZIP 6.8 KB
2025-09-09 14:00 English ZIP 17.0 KB

Automate Your Workflow. Get a real-time feed of all ORASURE TECHNOLOGIES INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ORASURE TECHNOLOGIES INC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ORASURE TECHNOLOGIES INC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ABEONA THERAPEUTICS INC. Logo
A clinical-stage biopharma developing cell and gene therapies for rare diseases.
United States of America
ABEO
ABINGDON HEALTH PLC Logo
A CDMO specializing in lateral flow assays, offering development to manufacturing services.
United Kingdom
ABDX
ABIONYX Pharma Logo
Develops biotherapies and drug delivery vectors using apolipoprotein A-I.
France
ABNX
ABIVAX Logo
Clinical-stage biotech developing therapeutics for chronic inflammatory diseases.
France
ABVX
Abivax S.A. Logo
Clinical-stage biotech developing miRNA therapeutics for inflammatory diseases.
United States of America
ABVX
ABL Diagnostics Logo
Develops molecular diagnostic solutions for managing infectious diseases.
France
ABLD
Abliva Logo
Biopharmaceutical company developing medicines for primary mitochondrial diseases.
Sweden
ABLI
AB Science Logo
Researches and develops protein kinase inhibitors for human and veterinary medicine.
France
AB
ABVC BIOPHARMA, INC. Logo
Develops botanical drugs and medical devices for oncology, ophthalmology, and CNS.
United States of America
ABVC
ACADIA PHARMACEUTICALS INC Logo
Biopharmaceutical company developing medicines for CNS disorders and rare diseases.
United States of America
ACAD

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.